The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

By Kolho Kaija-Leena   Sipponen Taina  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 4, 2014-04 ,pp. : 434-441

Informa Healthcare

Access to resources Recommend Favorite

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease

By Reinders Claudia   Jonkers Daisy   Jansson Emmelie Å.   Stockbrügger Reinhold   Stobberingh Ellen   Hellström Per   Lundberg Jon  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 10, 2007-01 ,pp. : 1151-1157

Informa Healthcare

Access to resources Recommend Favorite

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

By Sipponen Taina   Kolho Kaija-Leena  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 7-8, 2010-08 ,pp. : 872-877

Informa Healthcare

Access to resources Recommend Favorite

Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

By Aomatsu Tomoki  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2372-2377

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

By  

Digestive Diseases, Vol. 31, Iss. 3-4, 2013-11 ,pp. : 336-344

Karger

Access to resources Recommend Favorite